Your Messages Inbox
Your Article Summary
See Latest ArticlesDecision About European Marketing Authorization for Oracea Postponed to 2008
MediGene, 07/31/07
MediGene AG has been informed by CollaGenex Pharmaceuticals Inc., that the decision about the European marketing authorization for the drug Oracea has been postponed. The committee of the nine countries involved in the decentralised procedure (Coordination Group for Mutual Recognition and Decentralised Procedures, CMD) did not reach a unanimous decision, and therefore refers the procedure to another committee for decision-making
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Bristol-Myers Squibb and Mead Johnson Announce Amendment and Extension of Exchange Offer
Bristol Myers-Squibb Company, 12/07/09
Prodesses ProParaflu+(TM) Assay Cleared for US Marketing by FDA
Gen-Probe, 12/03/09
Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic
Shire, 12/03/09
Article Search
Sponsor